Statins and Peripheral Arterial Disease: A Narrative Review

Peripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients with PAD, the presence of intermittent claudication leads to a deterioration in quality of life. In addition, even in asymptomatic cases, patients with PAD are at high risk of cardiac or cerebrovascular ev...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sergio Jansen-Chaparro, María D. López-Carmona, Lidia Cobos-Palacios, Jaime Sanz-Cánovas, M. Rosa Bernal-López, Ricardo Gómez-Huelgas
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/eedbdd44b7164bd286186756619f2d22
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eedbdd44b7164bd286186756619f2d22
record_format dspace
spelling oai:doaj.org-article:eedbdd44b7164bd286186756619f2d222021-11-22T06:05:30ZStatins and Peripheral Arterial Disease: A Narrative Review2297-055X10.3389/fcvm.2021.777016https://doaj.org/article/eedbdd44b7164bd286186756619f2d222021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fcvm.2021.777016/fullhttps://doaj.org/toc/2297-055XPeripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients with PAD, the presence of intermittent claudication leads to a deterioration in quality of life. In addition, even in asymptomatic cases, patients with PAD are at high risk of cardiac or cerebrovascular events. Treatment of PAD is based on lifestyle modifications; regular exercise; smoking cessation; and control of cardiovascular risk factors, including hypercholesterolemia. A growing number of studies have shown that statins reduce cardiovascular risk and improve symptoms associated with PAD. Current guidelines recommend the use of statins in all patients with PAD in order to decrease cardiovascular events and mortality. However, the prescribing of statins in patients with PAD is lower than in those with coronary heart disease. This review provides relevant information from the literature that supports the use of statins in patients with PAD and shows their potential benefit in decreasing lower limb complications as well as cardiovascular morbidity and mortality.Sergio Jansen-ChaparroMaría D. López-CarmonaLidia Cobos-PalaciosJaime Sanz-CánovasM. Rosa Bernal-LópezM. Rosa Bernal-LópezRicardo Gómez-HuelgasRicardo Gómez-HuelgasFrontiers Media S.A.articlestatinsperipheral arterial diseasecardiovascular riskamputationcritical limb ischemiaDiseases of the circulatory (Cardiovascular) systemRC666-701ENFrontiers in Cardiovascular Medicine, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic statins
peripheral arterial disease
cardiovascular risk
amputation
critical limb ischemia
Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle statins
peripheral arterial disease
cardiovascular risk
amputation
critical limb ischemia
Diseases of the circulatory (Cardiovascular) system
RC666-701
Sergio Jansen-Chaparro
María D. López-Carmona
Lidia Cobos-Palacios
Jaime Sanz-Cánovas
M. Rosa Bernal-López
M. Rosa Bernal-López
Ricardo Gómez-Huelgas
Ricardo Gómez-Huelgas
Statins and Peripheral Arterial Disease: A Narrative Review
description Peripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients with PAD, the presence of intermittent claudication leads to a deterioration in quality of life. In addition, even in asymptomatic cases, patients with PAD are at high risk of cardiac or cerebrovascular events. Treatment of PAD is based on lifestyle modifications; regular exercise; smoking cessation; and control of cardiovascular risk factors, including hypercholesterolemia. A growing number of studies have shown that statins reduce cardiovascular risk and improve symptoms associated with PAD. Current guidelines recommend the use of statins in all patients with PAD in order to decrease cardiovascular events and mortality. However, the prescribing of statins in patients with PAD is lower than in those with coronary heart disease. This review provides relevant information from the literature that supports the use of statins in patients with PAD and shows their potential benefit in decreasing lower limb complications as well as cardiovascular morbidity and mortality.
format article
author Sergio Jansen-Chaparro
María D. López-Carmona
Lidia Cobos-Palacios
Jaime Sanz-Cánovas
M. Rosa Bernal-López
M. Rosa Bernal-López
Ricardo Gómez-Huelgas
Ricardo Gómez-Huelgas
author_facet Sergio Jansen-Chaparro
María D. López-Carmona
Lidia Cobos-Palacios
Jaime Sanz-Cánovas
M. Rosa Bernal-López
M. Rosa Bernal-López
Ricardo Gómez-Huelgas
Ricardo Gómez-Huelgas
author_sort Sergio Jansen-Chaparro
title Statins and Peripheral Arterial Disease: A Narrative Review
title_short Statins and Peripheral Arterial Disease: A Narrative Review
title_full Statins and Peripheral Arterial Disease: A Narrative Review
title_fullStr Statins and Peripheral Arterial Disease: A Narrative Review
title_full_unstemmed Statins and Peripheral Arterial Disease: A Narrative Review
title_sort statins and peripheral arterial disease: a narrative review
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/eedbdd44b7164bd286186756619f2d22
work_keys_str_mv AT sergiojansenchaparro statinsandperipheralarterialdiseaseanarrativereview
AT mariadlopezcarmona statinsandperipheralarterialdiseaseanarrativereview
AT lidiacobospalacios statinsandperipheralarterialdiseaseanarrativereview
AT jaimesanzcanovas statinsandperipheralarterialdiseaseanarrativereview
AT mrosabernallopez statinsandperipheralarterialdiseaseanarrativereview
AT mrosabernallopez statinsandperipheralarterialdiseaseanarrativereview
AT ricardogomezhuelgas statinsandperipheralarterialdiseaseanarrativereview
AT ricardogomezhuelgas statinsandperipheralarterialdiseaseanarrativereview
_version_ 1718418136835817472